Carregant...
Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience
OBJECTIVE: Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease of the platelet count to less than 100x109/L. Although it is included in a benign disease group, bleeding complications may be mortal. With a better understanding of the pathophys...
Guardat en:
| Publicat a: | Turk J Haematol |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Galenos Publishing
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4805331/ https://ncbi.nlm.nih.gov/pubmed/25914025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.2014.0152 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|